Navigation Links
Viscosity, Whole Blood

ProductsViscosity, Whole Blood
Company ARUP Laboratories
Item Viscosity, Whole Blood
Features 
Description ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' clients include more than half of the nation's university teaching hospitals and children's hospitals, major commercial laboratories, military and government facilities, and major clinics.
Info ARUP Laboratories
Customer Service: (800) 522-2787
Web site: http://www.aruplab.com

Related medicine products :

1. Viscosity, Serum
2. Series 590 Low Cost Whole Blood Aggregometers
3. ACCUTEST Mononucleosis Whole Blood Test
4. ACCUTEST H. pylori Test (Whole Blood)
5. SST-1 Whole-field Scotopic Sensitivity Tester
6. Liquichek Whole Blood Volatiles Control
7. Lyphochek Whole Blood Control
8. Lyphochek Whole Blood Metals Control
9. Model 700 Whole Blood/Optical Lumi-Aggregometer
10. Glass Whole Blood Tube with K3EDTA
11. Whole Body Hypothermia System
...reference laboratory and a worldwide leader in inn...offers an extensive test menu of highly complex an...thology. Owned by the University of Utah, ARUP Lab...ation's university teaching hospitals and children...
...reference laboratory and a worldwide leader in inn...offers an extensive test menu of highly complex an...thology. Owned by the University of Utah, ARUP Lab...ation's university teaching hospitals and children...
...reference laboratory and a worldwide leader in inn...offers an extensive test menu of highly complex an...thology. Owned by the University of Utah, ARUP Lab...ation's university teaching hospitals and children...
...reference laboratory and a worldwide leader in inn...offers an extensive test menu of highly complex an...thology. Owned by the University of Utah, ARUP Lab...ation's university teaching hospitals and children...
Medicine Products:
(Date:11/21/2008)...Y, Calif., Nov. 21 Album Creative ..., launches a new program offering big brand market...n the large, expensive ad agency process and servi...very hands-on approach," says Matt Parker, Creativ...mbines experience and proven brand-building techni...
(Date:11/21/2008).... 21, 2008)The University of Texas Health Science ...ing Excellence in Aging Studies (TEXAS), to promot...stigious $2 million award from the Donald W. Reyno...., "This will allow us to teach geriatric medicin...cal student to practicing physicians. With the rea...
(Date:11/21/2008)...ers remain cautious about future antibiotic resist...ov. 21 (HealthDay News) -- People with moderate to...D) may be able to reduce the frequency of exacerba...biotic, a new report says. , The study, publis...an Journal of Respiratory and Critical Care Medici...
(Date:11/21/2008)..., Nov. 21 NursingCenter.com, the p...on and peer reviewed content, has been,updated to...0 registered,users. Powered by Lippincott William...ides over 900 peer-reviewed continuing education a... more than 50 leading nursing journals.,Lippincot...
Breaking Medicine News(10 mins):Health News:Album Creative Studios Tailors Big Brand Marketing For Small Businesses 2Health News:UT Houston launches geriatric training with $3.25 million in grant, matching funds 2Health News:UT Houston launches geriatric training with $3.25 million in grant, matching funds 3Health News:UT Houston launches geriatric training with $3.25 million in grant, matching funds 4Health News:Long-Term Erythromycin Cut COPD Complications 2Health News:NursingCenter.com Launches New Features to Improve User Experience 2Health News:NursingCenter.com Launches New Features to Improve User Experience 3
...te House has declared on Thursday that it would ex...s from the new law which requires them to give pro...rth certificates or other documents. This move wa...a ruling by a federal judge who is scheduled to ho...
...riched with long chain polyunsaturated fatty acids... situation, have not fully normalized their //meta..., lead author of the study have reported that impr...reversing the metabolic profiles (a health indicat...
...ng to a survey done by the Canadian Institute of M... of the Canadian’s daily calories//. They lack a ... effects. About 25% of those aged 31 to 50 derived...which is the main cause of various health risks. ...
... Professionals’ comments on banning sugary drinks ...sity lobby groups//. Health Minister Pete Hodgso... by 2008 to help fight the obesity epidemic has be... weak evidence" by Associate Professor Wayne Cutfi...
Other Medicine News:Health News:Bush Administration to Exempt Medicaid Recipients on Proof of Citizenship 2Health News:'Diet Modifications' - less effective against Stress 2Health News:Anti-Obesity Groups Criticize Response of Medical Professionals 2
(Date:11/19/2008)...AND OAKS, Calif., Nov. 19 /PRNewswire-FirstCall/ -...eda Oncology Company, a subsidiary of,Takeda Phar...unced that,enrollment in the Phase 3 MONET1 trial...th paclitaxel and carboplatin for the first-line t...NSCLC) has been temporarily suspended,following a...
(Date:11/19/2008)...OCHELLE, N.Y., Nov. 19 Biotech sci...ogies to toxicology research to better understand ...of organ systems, reports Genetic Engineering &am...y interested in figuring out a new compound,s mech...tive toxicology technique, according to the Novemb...
(Date:11/18/2008)...N, November 19 NeuroDisc...rvice provider and drug development Company,and ...x: 4565), a leading,international biopharmaceutic... presenting further pivotal pre-clinical efficacy ... is a potential therapy for neuropathic pain and h...
(Date:11/18/2008)...OWNE, Va., Nov. 18 Fort...hered at a November national forum to consider cut...blic health and national economy from outbreaks of...unced today. , , Among those innovations: ,...y American kitchen table that detects highly conta...
Breaking Medicine Technology:Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 2Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 3Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 4Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 5Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 6Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 7GEN Reports on the Trend Toward Predictive Toxicogenomics 2Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 2Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 342 Top U.S. Scientists and Specialists Explore Cutting-Edge Innovations to Defend America From Dangerous Zoonotic Diseases 2Holiday Gifts for Those With Disabilities 26 Other Special Needs 4005 1Holiday Gifts for Those With Disabilities 26 Other Special Needs 4005 2Shopping Sprees Can Cost More Than You Think 3A How to Identify a Shopping Addiction 4002 1Shopping Sprees Can Cost More Than You Think 3A How to Identify a Shopping Addiction 4002 2Shopping Sprees Can Cost More Than You Think 3A How to Identify a Shopping Addiction 4002 3Study 3A HPV test beats Pap in detecting cervical cancer 4000 1Study 3A HPV test beats Pap in detecting cervical cancer 4000 2Study 3A HPV test beats Pap in detecting cervical cancer 4000 3OrbusNeichs Genous 28TM 29 Bio Engineered R Stent 28TM 29 is Subject of Sessions on Innovation at TCT 2007 559 1OrbusNeichs Genous 28TM 29 Bio Engineered R Stent 28TM 29 is Subject of Sessions on Innovation at TCT 2007 559 2
...ROUCK HEIGHTS, N.J.--(BUSINESS WIRE)--Jun 21, 2007... today announced that,detailed results from the Co...benign prostatic hyperplasia (BPH) will be present...beginning in September,at the South Central Americ...ngs. These independent podium presentations will b...
...CAGO, June 21, 2007 /PRNewswire/ -- , What and Whe... ACTOS(R),(pioglitazone HCl) will be presented in ...he American Diabetes Association in,Chicago: , , ...n high-risk type 2, diabetes patients treat... PROactive; Poster 0553-P presented on Saturda...
Other Medicine Technology:Nymox Announces NX-1207 Data to Be Presented at Upcoming U.S.,Urology Meetings 2MEDIA ADVISORY: Subsets of Landmark Diabetes Trials Investigating,MacroVascular Outcomes Presented at the American Diabetes,Association 67th Scientific Sessions 2MEDIA ADVISORY: Subsets of Landmark Diabetes Trials Investigating,MacroVascular Outcomes Presented at the American Diabetes,Association 67th Scientific Sessions 3